SCHEMBL5173273

SCHEMBL5173273

CC(C)Oc1ccc([C@@H](C(N)=O)C(=O)NC2CCOCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MITF O75030 1/20 0.42
GLA P06280 1/20 0.42
PARP10 Q53GL7 1/20 0.41
SMYD3 Q9H7B4 1/20 0.41
ACACB O00763 3/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
MDM2 Q00987 1/20 0.40
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
FPR2 P25090 1/20 0.38
CTSD P07339 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5171498 0.88 ALDH1A1 (0.47) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL5172331 0.81 ACACB (0.41) NPC1RAB9AMEN1KMT2ASMYD3
SCHEMBL631342 0.79 SMN1; SMN2 (0.46) SMN1; SMN2NPC1HPGDRAB9AMEN1
SCHEMBL5170764 0.79 TSHR (0.59) MEN1KMT2APOLBTSHRHTT
SCHEMBL5171793 0.78 CTSD (0.51) MEN1KMT2ACTSD
SCHEMBL5173129 0.76 GLA (0.57) SMN1; SMN2MEN1KMT2AGLAPARP10
SCHEMBL5170058 0.73 HPGDS (0.46) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL23053135 0.69 SMN1; SMN2 (0.45) SMN1; SMN2NPC1HPGDRAB9AMEN1
SCHEMBL631341 0.69 SMN1; SMN2 (0.39) SMN1; SMN2NPC1HPGDRAB9AACACB
SCHEMBL17373709 0.67 SMYD3 (0.39) HPGDSMYD3TSHRHTTFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP claimed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO claimed
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed